Patient-Reported Outcomes
peritoneal disseminated disease from, Anxiety, anxiety-specific Speilberger, Cancer
OVARIAN CANCER, SECONDARY, CANCER
An additional secondary end point was difference in quality of life (QOL) between the treatment and observation periods. QOL was determined using 3 different questionnaires: the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30); the ovarian cancer-specific EORTC QOL questionnaire (EORTC QLQ-OV28), due to the considerable similarity in symptoms of peritoneal disseminated disease from ovarian cancer, and the anxiety-specific Speilberger State/Trait Anxiety Inventory State (STAI) scale.